About Pipeline Strategy Events Investors News Contact
 
  about advanced cancer therapeutics  
 

founders & management

Dale J. Boden
Chairman of Advanced Cancer Therapeutics

Dale J. Boden is a founder and Chairman of Advanced Cancer Therapeutics. He also serves as President and CEO of B F Capital, Inc., a Louisville, KY based private investment firm. Investing primarily in real estate, venture capital and early-stage or special situation growth companies, B F Capital provides both equity capital and management assistance.

Since founding B F Capital in 1993, Mr. Boden has overseen investments in more than 65 different companies and partnerships. In 2003, the Yearling Fund I, L.P. was formed by Mr. Boden and his two partners, Tyree Wilburn and William Lomicka. The Yearling Fund is an early stage venture capital fund focused on Kentucky-based companies. Mr. Boden serves on the boards of Antisoma, Plc. (ASM.L), Bradmer Pharmaceuticals, Inc. (BMR.TSX) and several private companies serving in varying capacities including Audit and Compensation Committee Chair, Lead Director and non-executive Chairman of the Board. Mr. Boden has profound experience in Corporate Development, M & A, Corporate Finance and General Management.
Dale J. Boden
Chairman
Go to next bio